Tag: mitochondrial

April 25, 2018

Reata Announces New Preclinical Data Demonstrating the Potential of Omaveloxolone

Reata Pharmaceuticals (Nasdaq:RETA) a clinical-stage biopharmaceutical company, today announced new preclinical data demonstrating that omaveloxolone potently activates the Keap1/Nrf2 pathway,...
March 2, 2018

Reata Announces Top-Line Data from the Dose-Escalation Cohorts of the Phase 2 Motor Study

Reata Pharmaceuticals (Nasdaq:RETA) a clinical-stage biopharmaceutical company, announced top-line data from the dose-escalation cohorts of the Phase 2 MOTOR trial...
February 13, 2017

What is Longevity Investing?

A look at longevity investing and achieving longevity for life.
December 29, 2016

Top Genetics News Stories of 2016

From precision meds to the ongoing CRISPR-Cas9 saga, here are the top genetics news stories of 2016. We expect each...
December 12, 2016

Reata Pharmaceuticals Announces Requested Withdrawal of Registration Statement Due to Adverse Market Conditions

Reata Pharmaceuticals, a clinical-stage biopharmaceutical company, today announced that, due to adverse market conditions, it has requested withdrawal of its...
December 6, 2016

Reata Pharmaceuticals Announces Filing of Registration Statement for Proposed Public Offering

Reata Pharmaceuticals, a clinical-stage biopharmaceutical company, today announced that it has filed a registration statement on Form S-1 with the...
November 9, 2016

MEI Pharma Reports First Quarter Fiscal Year 2017 Results

MEI Pharma, an oncology company focused on the clinical development of novel therapies for cancer, today reported results for its...